Dendritic Nanotechnologies and Lumera Sign Joint Research Agreement
DNT will build chemistries on proprietary Lumera surfaces in the area of dendrimers.
Genetic Analysis of Glioblastoma Brain Tumors Can Aid in Treatment Decisions
The study shows that genetic analysis of glioblastomas can predict the tumors' sensitivity to specific drugs.
Genesis Bioventures Announces Restructuring Management Agreement
Genesis Bioventures has retained Experigen Management Company to lead its reorganization and restructuring.
Publication Shows Cancer Biomarker Identification in Formalin-Fixed Tissue
The article describes LC MS/MS mass spectrometry analysis of FFPE prostate cancer tissue.
Velcura Therapeutics and GeneGo Enter Multi Year Agreement
All Velcura employees will have access to the MetaCore database.
Gene Variants Predict Heart Muscle Damage After Cardiac Surgery
Researchers have identified six gene variants that are associated with the incidence of post-operative myocardial infarction.
Twin Molecular Scissors Link Creation of MicroRNAs With Gene-Silencing
Researchers have identified a two-protein complex which controls the earliest steps in the creation of miRNAs.
Hybrigenics Names New CEO and Board Chairman
Remi Delansorne has been appointed as CEO and Daan Ellens as Chairman of the Board.
Metabolon Appoints Chief Scientific Officer
Dr. Michael Milburn has been appointed as Chief Scientific Officer.
FDA and Industry Collaborate to Predict Liver Toxicity in Human Drug Trials
The liver toxicology biomarker study aims to discover signs of human liver toxicity.